Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure: A Thai University Hospital setting

Journal of the Medical Association of Thailand

Volumn 89, Issue 7, 2006, Pages 974-978

  Kiertiburanakul, Sasisopin ^a   Wannaying, Bunchong ^a   Tonsuttakul, Sirirat ^a   Kehachindawat, Pranee ^a   Apivanich, Siriluk ^a   Somsakul, Somporn ^a   Malathum, Kumthorn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adverse event; Antiretroviral drug; Health care worker; HIV; Postexposure prophylaxis

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ABDOMINAL PAIN; ANOREXIA; DIARRHEA; DIZZINESS; FATIGUE; FLU LIKE SYNDROME; HEADACHE; HEALTH CARE PERSONNEL; HEMATURIA; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NAUSEA; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; RASH; RETROSPECTIVE STUDY; REVIEW; THAILAND; UNIVERSITY HOSPITAL; VOMITING;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEALTH PERSONNEL; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; OCCUPATIONAL EXPOSURE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND;

EID: 33746191791     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Gerberding JL. Clinical practice. Occupational exposure to HIV in health care settings. N Engl J Med 2003; 348: 826-33.
2. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med 1993; 153: 1451-8.
3. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102: 9-15.
4. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337: 1485-90.
5. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 2000; 13: 385-407.
6. Black RJ. Animal studies of prophylaxis. Am J Med 1997; 102: 39-44.
7. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
8. Patrick DM. HIV postexposure prophylaxis: new recommendations. CMAJ 1997; 156: 233-4.
9. Manion DJ, Hirsch MS. Combination chemotherapy for human immunodeficiency virus-1. Am J Med 1997; 102: 76-80.
10. Robinson EN Jr. Arguments against the chemo-prophylactic use of zidovudine following occupational exposure to the human immunodeficiency virus. Clin Infect Dis 1993; 16: 357-60.
11. Tsai CC, Emau P, Follis KE, Beck TW, Benveniste RE, Bischofberger N, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998; 72: 4265-73.
12. Lee LM, Henderson DK. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV. Drug Saf 2001; 24: 587-97.
13. Wang SA, Puro V. Toxicity of post-exposure prophylaxis for human immunodeficiency virus. In: Panlilio L, editor. Balliere's clinical infectious diseases. London: Balliere-Tindall; 1999: 349-63.
14. Puro V, Ippolito G. Issues on antiretroviral post exposure combination prophylaxis. J Biol Regul Homeost Agents 1997; 11: 11-9.
15. Swotinsky RB, Steger KA, Sulis C, Snyder S, Craven DE. Occupational exposure to HIV: experience at a tertiary care center. J Occup Environ Med 1998; 40: 1102-9.
16. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001; 50: 1-52.
17. Wang SA, Panlilio AL, Doi PA, White AD, Stek M Jr, Saah A. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry. Infect Control Hosp Epidemiol 2000; 21: 780-5.
18. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep 2001; 49: 1153-6.
19. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356: 1423-30.